Olayinka Kotila - Faculty of Pharmacy, University of Ibadan

基本信息

Career Trajectory

Bio

As earlier stated, my research focus is on pharmacokinetics and pharmacogenetics with interest in both communicable and non-communicable diseases. Due to low economic resource, my key method for genotyping is using PCR-based methods coupled with Hplc analysis for quantitation of drugs and metabolites in biosamples. I'm presently looking at how to employ taqman-based assays for genotyping more drug metabolising enzymes

Research Interests

Papers共 21 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Building Capacity for Drug Development Process in Africa‒A Workable Model

Chinedum Peace Babalola,Olayinka Adejoke Kotila,Babatunde B. Samuel,Oladapo Adetunji,Grace Olusola Gbotosho,Jones O. Moody, Adewale Muyiwa Adeyemi, Olufemi Adegbola, Gbekel'Oluwa Akinyele,Oludele A. Itiola,Joseph Fortunak

PHARMACY EDUCATIONno. 1 (2024): 1-12

Cited0Views0Bibtex

The Expanding Role of Gene-Based Prescribing for Phase II Drug-Metabolizing Enzymes

Chinedum P. Babalola,Olayinka Kotila,Otito F. Iwuchukwu

American journal of pharmacotherapy and pharmaceutical sciences (2023): 24-24

Cited0Views0Bibtex

Non-compartmental and Population Pharmacokinetic Analysis of Dapsone in Healthy NIGERIANS: A Pilot Study

Olayinka A. A. Kotila, David T. T. Ajayi, Collen Masimerembwa,Roslyn Thelingwani,Abayomi Odetunde,Adeyinka G. G. Falusi,Chinedum P. P. Babalola

BRITISH JOURNAL OF CLINICAL PHARMACOLOGYno. 11 (2023): 3454-3459

Cited0Views0WOSBibtex

Data Science Training Needs in Sub-Saharan Africa: Implications for Biomedical Research and Therapeutics Capacity

Modupe O. Coker,Olayinka A. Kotila,Taiwo O. Adigun,Temitayo V. Lawal,Adeniyi F. Fagbamigbe,Angela U. Makolo,Mobolaji M. Salawu,David T. Ajayi,Paul E. Oluniyi,Judith U. Oguzie,Anise N. Happi, Anne G. Hoen,Chinedum P. Babalola,IkeOluwapo O. Ajayi

Open Research Africa (2023)

Cited0Views0Bibtex

Comparison of Efavirenz Levels in Blood and Hair with Pharmacy Refills As Measures of Adherence and Predictors of Viral Suppression among People Living with HIV in Nigeria

Nwogu Jacinta N.,Ngene Samuel O.,Babalola Chinedum P.,Olagunju Adeniyi,Owen Andrew,Khoo Saye H.,Kotila Olayinka A.,Berzins Baiba,Okochi Hideaki,Tallerico Regina,Gandhi Monica,Taiwo Babafemi

AIDS research and therapy（2022）

Cited1Views0WOSBibtex

Oncology Training Needs Assessment among Health Care Professionals in Nigeria

Prisca Olabisi Adejumo,Mojisola Morenike Oluwasanu,Atara Ntekim,Olutosin Alaba Awolude,Olayinka Adejoke Kotila,Toyin Aniagwu,Biobele Jotham Brown,Bonaventure Suiru Dzekem, Susan Duncan,Moyinoluwalogo Tito-Ilori, Olufadekemi Ajani,Sang Mee Lee,Chinedum Peace Babalola,Oladosu Ojengbede,Dezheng Huo,Nazik Hammad,Olufunmilayo Olopade

JCO global oncology（2022）

Cited0Views0WOSBibtex

Quinoline Antimalarials Increase The Antibacterial Activity Of Ampicillin

Olajumoke A Olateju,Chinedum P Babalola,Olujide O Olubiyi,Olayinka A Kotila,David A Kwasi,Anderson O Oaikhena,Iruka N Okeke

FRONTIERS IN MICROBIOLOGY（2021）

Cited9Views0WOSBibtex

ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women with HER2-Positive Breast Cancer: A Study Protocol

Atara I. Ntekim,Abiola Ibraheem,Adenike A. Sofoluwe,Olayinka Kotila,Chinedum Babalola,Theodore Karrison,Christopher O. Olopade

JCO GLOBAL ONCOLOGY（2020）

Cited2Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn